U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07049575) titled 'Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa' on June 25.
Brief Summary: The purpose of this study is to evaluate the maximal use of ruxolitinib cream in adult and adolescent participants with hidradenitis suppurativa.
Study Start Date: Sept. 15
Study Type: INTERVENTIONAL
Condition:
Hidradenitis Suppurativa
Intervention:
DRUG: Ruxolitinib Cream
Ruxolitinib cream applied topically to the affected area as a thin film twice daily.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Incyte Corporation
Published by HT Digital Content Services with permissio...